⚡️ TrumpRx: Pfizer Strikes Deal With Trump Administration

President Donald Trump just unveiled TrumpRx, a government-backed platform that allows Americans to buy some prescription drugs directly — bypassing insurers and pharmacy middlemen. Alongside that, Pfizer agreed to significant price cuts and will adopt most favored nation (MFN) pricing for future drug launches and Medicaid sales. In this short, we cover: What TrumpRx is and how it works The discounts Pfizer agreed to (40%–100%) on some drugs How MFN pricing will tie U.S. drug prices to those paid in other developed nations Pfizer’s $70B commitment to U.S. manufacturing and R&D Risks and open questions: import tariffs, excluded drugs, legal pushback, and whether the plan can scale Is this the turnaround U.S. drug pricing needed — or just a big political move? Share your take below. #Pfizer #TrumpRx #Healthcare 🌐 Want more market-moving insights? Dive deeper at www.benzinga.com — your one-stop destination for the latest financial news, data, and expert analysis to stay ahead of the markets. 📲 Let’s stay connected! Follow us for real-time updates, market tips, and exclusive content: 🔹 Instagram: https://www.instagram.com/benzinga 🔹 Facebook: https://www.facebook.com/benzinga 🔹 TikTok: https://www.tiktok.com/@benzinga 🔹 X: https://www.x.com/benzinga ⚠️ Disclaimer: Investing in financial markets carries risk, and there are no guaranteed returns. All information is for educational purposes only and should not be taken as financial advice. Always do your own research and speak with a qualified financial advisor before making investment decisions. Only invest what you can afford to lose. Past performance does not guarantee future outcomes.